# A Comparative Study of Artekin With Standard Malarial Treatment Regimes in Afghanistan

> **NCT00682578** · PHASE3 · COMPLETED · sponsor: **University of Oxford** · enrollment: 1086 (actual)

## Conditions studied

- Uncomplicated Falciparum Malaria
- Vivax Malaria

## Interventions

- **DRUG:** Dihydroartemisinin + Piperaquine (Artekin)
- **DRUG:** artesunate-sulphadoxin/pyrimethamine, chloroquine

## Key facts

- **NCT ID:** NCT00682578
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 1086 (ACTUAL)
- **Last updated:** 2018-05-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00682578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00682578, "A Comparative Study of Artekin With Standard Malarial Treatment Regimes in Afghanistan". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00682578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*